PolyPeptide Group Announces Annual General Meeting 2024

PolyPeptide Group AG, a leading global CDMO specializing in peptide and oligonucleotide-based active pharmaceutical ingredients, has officially released the invitation to its third annual General Meeting scheduled for April 10, 2024. The meeting will convene at the Chollerhalle, Zug. This year, the board will see re-elections, including Peter Wilden as Chair, with the exception of Dorothee A. Deuring who will not seek re-election.

In addition to board elections, the agenda includes proposed changes to the company's Articles of Association and decisions on remuneration. Specifically, there's a proposal to remove a clause related to board members' consulting fees, aiming to uphold the objectivity and independence of board members. Shareholders will also vote on auditors, proxies, and various financial approvals, including the Management Report and Consolidated Financial Statements for the fiscal year 2023.

The detailed proposals and relevant documents for the forthcoming AGM are accessible on PolyPeptide Group's website, ensuring stakeholders are well-informed ahead of the pivotal meeting.